![Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study - Budoff - 2018 - Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study - Budoff - 2018 -](https://onlinelibrary.wiley.com/cms/asset/59a17799-4cd2-4f46-bdeb-a675b505f641/clc22856-fig-0001-m.jpg)
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study - Budoff - 2018 -
![Dr Reddys Laboratories: Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US - The Economic Times Dr Reddys Laboratories: Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US - The Economic Times](https://img.etimg.com/thumb/width-1200,height-900,imgsize-10766,resizemode-75,msid-83738741/industry/healthcare/biotech/pharmaceuticals/dr-reddys-laboratories-launches-icosapent-ethyl-capsules-in-us.jpg)
Dr Reddys Laboratories: Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US - The Economic Times
VASCEPA® (icosapent ethyl) Capsules, for oral use Initial U.S. Approval: 2012These highlights do not include all the informatio
![These highlights do not include all the information needed to use ICOSAPENT ETHYL CAPSULES safely and effectively. See full prescribing information for ICOSAPENT ETHYL CAPSULES. ICOSAPENT ETHYL capsules, for oral useInitial U.S. These highlights do not include all the information needed to use ICOSAPENT ETHYL CAPSULES safely and effectively. See full prescribing information for ICOSAPENT ETHYL CAPSULES. ICOSAPENT ETHYL capsules, for oral useInitial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-01.jpg&id=700018)